Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M741Revenue $M13.5Net Margin (%)-390.3Z-Score19.1
Enterprise Value $M633EPS $-1.4Operating Margin %-157.5F-Score4
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-123.9Higher ROA y-yN
Price/Book6.110-y EBITDA Growth Rate %-19.4Quick Ratio9.7Cash flow > EarningsY
Price/Sales37.25-y EBITDA Growth Rate %-10.9Current Ratio9.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-65.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)4ROE % (ttm)-86.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M60.4ROI % (ttm)-83.0Gross Margin Increase y-yN

Gurus Latest Trades with INO

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INOJean-Marie Eveillard 2014-03-31 Sold Out $9.76 - $15.28
($11.92)
$ 12.192%Sold Out0
INOJean-Marie Eveillard 2013-12-31 Buy $6.92 - $11.88
($8.28)
$ 12.1947%New holding, 250000 sh.250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INO is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


INO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIES PETERCFO 2014-10-09Buy3,960$10.121.88 view
COLLINS MORTONDirector 2014-08-21Buy8,000$10.0122.98 view
COLLINS MORTONDirector 2014-08-20Buy40,600$9.7426.39 view
Sardesai NiranjanCOO 2014-08-12Buy2,550$8.741.49 view
Kim Jong JosephCEO 2014-08-12Buy250,000$9.0635.87 view
Kim Jong JosephCEO 2014-04-15Buy6,250$936.78 view
COLLINS MORTONDirector 2013-11-13Buy63,625$7.2869.09 view
Bagarazzi MarkChief Medical Officer 2013-04-16Buy15,000$2.24449.55 view
Kim Jong JosephCEO, 10% Owner 2013-04-02Buy22,500$2515.5 view
Cabrera AngelDirector 2013-03-22Buy10,000$2.16469.91 view

Press Releases about INO :

    Quarterly/Annual Reports about INO:

    News about INO:

    Articles On GuruFocus.com
    Inovio CEO Invests in 250,000 Shares of Company Stock Aug 13 2014 
    comment on INO May 10 2013 
    Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
    Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW Jun 17 2012 
    Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 
    Any opinions regarding Apr 12 2010 

    More From Our Partners
    Making Money With Charles Payne: 10/16/14 Oct 16 2014 - FOXBUSINESS

    More From Other Websites
    The 3 Most Volatile Biotech Stocks Oct 14 2014
    3 Big-Volume Biotech Stocks to Trade for Breakouts Oct 06 2014
    Inovio CEO: New Ebola vaccine effective in animals Oct 01 2014
    Making Money With Charles Payne: 10/01/14 Oct 01 2014
    [video] Inovio's Ebola vaccine in pipeline Oct 01 2014
    Inovio's Ebola vaccine in pipeline Oct 01 2014
    Ahead of the Bell: Ebola treatment makers rise Oct 01 2014
    Ahead of the Bell: Ebola treatment makers rise Oct 01 2014
    Making Money With Charles Payne: 09/30/14 Oct 01 2014
    Shares of companies testing Ebola vaccines rise Sep 30 2014
    Shares of companies testing Ebola vaccines rise Sep 30 2014
    Inovio Pharmaceuticals Appoints Vice President of Commercial Development Sep 30 2014
    Scientists grapple with ethics in rush to release Ebola vaccines Sep 29 2014
    Inovio/GeneOne Life Science Collaborate for Ebola Vaccine Sep 25 2014
    Inovio Pharma plans humans trials of Ebola vaccine Sep 24 2014
    Inovio Pharma plans humans trials of Ebola vaccine Sep 24 2014
    Inovio to start human trials of Ebola vaccine Sep 24 2014
    [$$] Inovio, GeneOne to Advance Ebola Vaccine Sep 24 2014
    Inovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science Sep 24 2014
    Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers Sep 22 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK